Fig. 3From: Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancerSerum CA199 levels of patients before and after neoadjuvant chemotherapy. *P < 0.01, comparison of serum CA199 level of patients (after 4 courses of neoadjuvant chemotherapy) between the remission group (21.23±5.03 U/mL) and the ineffective group (44.29±3.13 U/mL)Back to article page